thymoquinone has been researched along with dinoprostone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Dreskin, SC; El Gazzar, M; El Mezayen, R; Marecki, JC; Nicolls, MR; Nomiyama, H | 1 |
| Banerjee, S; Kaseb, AO; Kong, D; Mohammad, M; Mohammad, RM; Padhye, S; Sarkar, FH; Wang, Z | 1 |
| Chen, MC; Day, CH; Hsu, HH; Huang, CY; Kuo, WW; Li, SY; Lin, YM; Padma, VV; Shih, HN; Tu, CC | 1 |
| Bhatia, HS; El-Bakoush, A; Fiebich, BL; Kumar, A; Lepiarz, I; Olajide, OA; Velagapudi, R | 1 |
| Afşar, E; Aslan, M; Çeker, T; Kırımlıoğlu, E; Yılmaz, Ç | 1 |
6 other study(ies) available for thymoquinone and dinoprostone
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation.
Topics: Allergens; Animals; Anti-Inflammatory Agents; Benzoquinones; Bronchial Hyperreactivity; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Dinoprostone; Disease Models, Animal; Female; Gene Expression Regulation; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Prostaglandin D2; Th2 Cells | 2006 |
Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Cytochromes c; Deoxycytidine; Dinoprostone; Drug Synergism; Female; Gemcitabine; Humans; Mice; Mice, Inbred ICR; Mice, SCID; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms | 2009 |
Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Phytochemicals; Signal Transduction | 2017 |
Inhibition of neuroinflammation by thymoquinone requires activation of Nrf2/ARE signalling.
Topics: Animals; Anti-Inflammatory Agents; Benzoquinones; Cell Line; Cell Survival; Cells, Cultured; Cytokines; Dinoprostone; Lipopolysaccharides; Mice; Microglia; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Rats, Sprague-Dawley; RNA, Messenger | 2017 |
Increased PUFA levels in kidney epithelial cells in the course of diclofenac toxicity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzoquinones; Cell Line; Cell Survival; Cyclooxygenase 1; Cytosol; Diclofenac; Dinoprostone; Epithelial Cells; Fatty Acids, Unsaturated; Humans; Kidney; Phospholipases A2 | 2020 |